Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-26

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the supplemental application for amlodipine besylate from Lupin Pharmaceuticals, making its generic calcium channel blocker available. Amlodipine b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)